NEW YORK, Oct. 17, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Immunotherapy Drugs Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 – COVID-19 Impact and Global Analysis – by type, clinical indication, end user, and geography" the global immunotherapy drugs market size is expected to grow from USD 186.32 billion in 2021 to USD 476.04 billion by 2028; it is expected to grow at a CAGR of 14.4% from 2022 to 2028.
Download Sample PDF Brochure of Immunotherapy Drugs Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00003416/
Global Immunotherapy Drugs Market Report Scope, Segmentations, Regional & Country Scope:
Report Coverage |
Details |
Market Size Value in |
USD 186.32 Billion in 2021 |
Market Size Value by |
USD 476.04 Billion by 2028 |
Growth rate |
CAGR of 14.4% from 2022 to 2028. |
Forecast Period |
2022-2028 |
Base Year |
2021 |
No. of Pages |
150 |
Historical data available |
Yes |
Segments covered |
Type, Clinical Indication, and End User |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Companies Covered |
Incyte Corporation, Juno Therapeutics, Celldex Therapeutics, Tesaro, Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Novartis AG, BioNTech SE, Sanofi, GlaxoSmithKline Plc, Pfizer Inc., Merck & Co, Johnson & Johnson |
Key Research Capabilities |
Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Global Immunotherapy Drugs Market Forecast to 2028 - Latest COVID-19 Analysis |
https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00003416/ |
Browse key market insights spread across 150 pages with list of tables & list of figures from the report, "Immunotherapy Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis - By Type (Vaccine Adjuvants, Dendritic Cell Activators & Growth Factors, T-Cell Stimulators & Growth Factors, Immune Checkpoint Inhibitors, Monoclonal Antibodies, Interleukins & Interferons, and Others), Clinical Indication (Cancer, Inflammatory Diseases, Autoimmune Diseases, Infectious Diseases, and Others), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others)" in detail along with the table of contents: https://www.theinsightpartners.com/reports/immunotherapy-drugs-market
Incyte Corporation; Pfizer Inc.; Juno Therapeutics; Novartis AG; Celldex Therapeutics; Tesaro, Inc; Amgen Inc; F. Hoffmann-La Roche Ltd; and Merck&Co. are a few of the key players profiled during the study of the global immunotherapy drugs market. Several other major companies were analyzed during this study to get a holistic view of the immunotherapy drugs market and its ecosystem.
Based on type, the global immunotherapy drugs market is segmented into vaccine adjuvants, dendritic cell activators & growth factors, T-cell stimulators & growth factors, immune checkpoint inhibitors, monoclonal antibodies, interleukins & interferons, and others. The monoclonal antibodies segment accounted for the largest market share in 2021, and it is expected to dominate the global immunotherapy drugs market over the forecast period. Moreover, for cancer treatment, only two monoclonal immunotherapy drugs have been approved, i.e., bevacizumab (Avastin) and ramucirumab (Cyramza). These drugs block blood vessels that supply nutrients to cancerous tumors. Further, other drugs are undergoing investigation in clinical trials across various countries. Medications that are studied in clinical trials include T-cell therapy, monoclonal antibodies (including immune checkpoint inhibitors), and oncolytic virus therapies. Immunomodulator medications targeting CTLA-4 inhibitors currently being studied for the treatment of lung cancers include tremelimumab and iplimumab.
Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00003416/
According to the National Cancer Institute, there were 1,806,590 new cancer cases in the US, and 606,520 associated deaths (mortalities) were registered in 2020. Moreover, according to the National Cancer Institute, the number of cancer survivors is expected to increase from 16.9 million in January 2019 to 22.2 million by 2030. As a result, manufacturers are inclined toward inventing novel approaches and methods that might curb the growth of cancer. Hence, cancer immunotherapy drugs, combined with radiation and chemotherapy treatments, prove to be an effective alternative to combat cancer. For instance, in January 2022, the US Food and Drug Administration (FDA) approved tebentafusp-tebn (KIMMTRAK), the bispecific fusion protein, for the treatment of HLA-A02:01-positive adult patients with unresectable uveal melanoma.
Based on clinical indications, the global immunotherapy drugs market is segmented into cancer, inflammatory diseases, autoimmune diseases, infectious diseases, and others. The cancer segment accounted for the largest market share in 2021, and it is expected to retain its dominance during the forecast period. In February 2022, the FDA approved the FoundationOne CDx, the companion diagnostic test, to identify patients with microsatellite instability high (MSI-H) solid tumors who may be candidates for immunotherapy. Moreover, the infectious diseases segment is expected to witness the highest CAGR from 2022 to 2028.
Based on end user, the global immunotherapy drugs market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment accounted for the largest market share in 2021, and it is expected to continue its dominance in the global immunotherapy drugs market over the forecast period. A rise in spending on immunotherapies by hospitals and high demand for advanced therapies that are only provided by hospitals & clinics are expected to support the growth of the immunotherapy drugs market.
Quickly Purchase Premium Copy of Immunotherapy Drugs Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00003416/
Go through further research published by The Insight Partners:
ISDN Modem Market - The global ISDN modem market size was valued US$ 982.97 thousand in 2022, it is estimated to register a CAGR of -80.6% from 2022 to 2024.
Semiconductor Bonding Market - The global semiconductor bonding market size was valued US$ 669.48 million in 2022, it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.
Recycled Ocean Plastics Market - The global recycled ocean plastics market size was valued at US$ 14,432.91 million in 2022, it is expected to grow at a CAGR of 8.5% from 2022 to 2028.
Femtech Market – The global femtech market size is expected to grow from US$ 11.63 billion in 2021 to US$ 22.29 billion by 2028, with an estimated CAGR of 9.9% from 2022 to 2028.
Women Healthcare Market – The global women healthcare market size was valued at US$ 30.5 billion in 2021 and is likely to reach US$ 42.8 billion by 2028; it is expected to grow at a CAGR of 4.8% between 2022 and 2028.
Orthopedic Implants Market – The global orthopedic implants market size is expected to grow from US$ 46,101.2 million in 2021 to US$ 67,235.1 million by 2028; it is expected to grow at a CAGR of 5.6% from 2022 to 2028.
Surgical Lasers Market – The global surgical lasers market size is expected to grow from US$ 3,625.96 million in 2021 to US$ 6,031.09 million in 2028, with an estimated CAGR of 7.7% from 2022 to 2028.
Immunotherapy Drugs Market – The global immunotherapy drugs market size is expected to grow from US$ 186.32 billion in 2021 to US$ 476.04 billion by 2028; it is expected to grow at a CAGR of 14.4% from 2022 to 2028.
Enteral Feeding Formulas Market – The global enteral feeding formulas market size is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2028 at a CAGR of 6.0% between 2022 and 2028.
Fetal Monitoring Market – The global fetal monitoring market size was valued at US$ 3,870.9 million in 2021 and is likely to reach a value of US$ 6,438.2 million by 2028 at a CAGR of 7.6% between 2022 and 2028.
Cell Culture Market – The global cell culture market size was valued at US$ 21,722.8 million in 2021 and is likely to reach US$ 44,330.1 million by 2028; it is expected to grow at a CAGR of 10.7% between 2022 and 2028.
Stroke Management Market – The global stroke management market size is expected to grow from US$ 33.48 billion in 2021 to US$ 55.37 billion by 2028; it is expected to grow at a CAGR of 7.5% from 2022 to 2028.
Diabetic Retinopathy Market – The global diabetic retinopathy market size is expected to grow from US$ 7.78 billion in 2021 to US$ 12.04 billion by 2028; it is expected to grow at a CAGR of 6.5% from 2022 to 2028.
Endotherapy Devices Market – The global endotherapy devices market size was valued at US$ 4,218.9 million in 2021 and is likely to reach US$ 6,494.4 million by 2028; it is expected to grow at a CAGR of 6.4% between 2022 and 2028.
Small Satellite Market – The global small satellite market size is expected to grow from US$ 5.8 Bn in 2021 to US$ 22.9 Bn by 2028 at a CAGR of 22.2% between 2022 and 2028.
Microgrid Market – The global microgrid market size is expected to grow from US$ 25 billion in 2021 to US$ 60 billion by 2028; it is estimated to grow at a CAGR of 17.0% during 2022–2028.
UV Disinfection Equipment Market – The global UV disinfection equipment market size is expected to grow from US$ 4.5 billion in 2021 to US$ 9.5 billion by 2028; it is expected to grow at a CAGR of 12.0% from 2022 to 2028.
Aircraft Electrification Market – The global aircraft electrification market size is expected to grow from US$ 1,977.47 million in 2021 to US$ 14,683.71 million by 2028; it is estimated to grow at a CAGR of 34.1% between 2022 and 2028.
Military Drone Market – The global military drone market size is expected to grow from US$ 11.70 billion in 2021 to US$ 31.38 billion by 2028 at a CAGR of 15.7% between 2022 and 2028.
Human Augmentation Market – The global human augmentation market size is expected to grow from US$ 116.88 Billion in 2021 to US$ 498.70 Billion by 2028 at a CAGR of 23.0% from 2022 to 2028.
Military Unmanned Surface Vehicle Market – The global military unmanned surface vehicle market size is expected to grow from US$ 1,512.32 million in 2021 to US$ 3,166.61 million by 2028 at a CAGR of 11.6% between 2022 to 2028.
Low GWP Refrigerants Market – The global Low GWP refrigerants market size is expected to grow from US$ 22.99 billion in 2021 to US$ 49.89 billion by 2028 at a CAGR of 11.7% between 2022 and 2028.
Food Testing Kits Market – The global food testing kits market size is expected to grow from US$ 20.73 billion in 2021 to US$ 34.14 billion by 2028 at a CAGR of 7.4% between 2022 and 2028.
Shelf-Life Testing Market – The global shelf-life testing market size is expected to grow from US$ 4.49 billion in 2021 to US$ 8.50 billion by 2028; it is estimated to grow at a CAGR of 8.9% between 2022 and 2028.
Acidity Regulators Market – The global acidity regulators market size accounted for approximately US$ 7 Bn in 2021 and is projected to exceed US$ 12 Bn by 2028 at a CAGR of 7.2% between 2022 and 2028.
3D Printing Metal Market – The global 3D printing metal market size is expected to grow from US$ 4.5 billion in 2021 to more than US$ 13 billion by 2028 at a CAGR of 16.5% between 2022 and 2028.
Building Automation System Market – The global building automation system (BAS) market size is expected to grow from US$ 70 billion in 2021 to US$ 175 billion by 2028 at a CAGR of 12% between 2022 and 2028.
Cocoa Derivatives Market – The global cocoa derivatives market size accounted for approximately US$ 26.00 billion in 2021 and is projected to exceed US$ 37.00 billion by 2028 with an estimated CAGR of 5.2% between 2022 and 2028.
Unmanned Helicopter Market – The global unmanned helicopter market size is expected to grow from US$ 3,095.76 Mn in 2021 to US$ 13,958.28 Mn by 2028 at a CAGR of 24.7% between 2022 and 2028.
Graph Database Market – The global graph database market size is expected to grow from US$ 1,854.0 million in 2021 to US$ 7,225.9 million by 2028; it is estimated to grow at a CAGR of 22.1% between 2022 and 2028.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/immunotherapy-drugs-market
Industry Research: https://www.einpresswire.com/newsroom/the_insight_partners/ | https://www.whatech.com/og/markets-research/companies/the-insight-partners-2019-05-20
Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg
Share this article